152 related articles for article (PubMed ID: 30860653)
1. Cost-effectiveness of an intervention to reduce fear of cancer recurrence: The ConquerFear randomized controlled trial.
Shih ST; Butow P; Bowe SJ; Thewes B; Turner J; Gilchrist J; Mihalopoulos C;
Psychooncology; 2019 May; 28(5):1071-1079. PubMed ID: 30860653
[TBL] [Abstract][Full Text] [Related]
2. Long-term efficacy and cost-effectiveness of blended cognitive behavior therapy for high fear of recurrence in breast, prostate and colorectal Cancer survivors: follow-up of the SWORD randomized controlled trial.
Burm R; Thewes B; Rodwell L; Kievit W; Speckens A; van de Wal M; Prins J
BMC Cancer; 2019 May; 19(1):462. PubMed ID: 31096934
[TBL] [Abstract][Full Text] [Related]
3. Psychological intervention (ConquerFear) for treating fear of cancer recurrence: mediators and moderators of treatment efficacy.
Sharpe L; Turner J; Fardell JE; Thewes B; Smith AB; Gilchrist J; Beith J; Girgis A; Tesson S; Day S; Grunewald K; Butow P;
J Cancer Surviv; 2019 Oct; 13(5):695-702. PubMed ID: 31347010
[TBL] [Abstract][Full Text] [Related]
4. Study protocol of ConquerFear-HK: a randomised controlled trial of a metacognition-based, manualised intervention for fear of cancer recurrence among Chinese cancer survivors.
Ng DWL; Fielding R; Tsang C; Ng C; Chan J; Or A; Kong IWM; Tang JWC; Li WWY; Chang ATY; Foo CC; Kwong A; Ng SS; Suen D; Chan M; Chun OK; Chan KKL; Butow PN; Lam WWT
BMJ Open; 2023 Jan; 13(1):e065075. PubMed ID: 36669845
[TBL] [Abstract][Full Text] [Related]
5. Cost-Effectiveness of a Psycho-Educational Intervention Targeting Fear of Cancer Recurrence in People Treated for Early-Stage Melanoma.
Dieng M; Khanna N; Kasparian NA; Costa DSJ; Butow PN; Menzies SW; Mann GJ; Cust AE; Morton RL
Appl Health Econ Health Policy; 2019 Oct; 17(5):669-681. PubMed ID: 31228015
[TBL] [Abstract][Full Text] [Related]
6. ConquerFear-Group: A randomized controlled trial of an online-delivered group-based psychological intervention for fear of cancer recurrence in breast cancer survivors.
Tauber NM; O'Toole MS; Jensen AB; Butow PN; Thewes B; Elkjaer E; Knutzen S; von Heymann A; Johansen C; Zachariae R
Psychooncology; 2023 Sep; 32(9):1424-1432. PubMed ID: 37489745
[TBL] [Abstract][Full Text] [Related]
7. Randomized Trial of ConquerFear: A Novel, Theoretically Based Psychosocial Intervention for Fear of Cancer Recurrence.
Butow PN; Turner J; Gilchrist J; Sharpe L; Smith AB; Fardell JE; Tesson S; O'Connell R; Girgis A; Gebski VJ; Asher R; Mihalopoulos C; Bell ML; Zola KG; Beith J; Thewes B
J Clin Oncol; 2017 Dec; 35(36):4066-4077. PubMed ID: 29095681
[TBL] [Abstract][Full Text] [Related]
8. Adefovir dipivoxil and pegylated interferon alfa-2a for the treatment of chronic hepatitis B: a systematic review and economic evaluation.
Shepherd J; Jones J; Takeda A; Davidson P; Price A
Health Technol Assess; 2006 Aug; 10(28):iii-iv, xi-xiv, 1-183. PubMed ID: 16904047
[TBL] [Abstract][Full Text] [Related]
9. Economic evaluation of a dietary intervention for adults with major depression (the "SMILES" trial).
Chatterton ML; Mihalopoulos C; O'Neil A; Itsiopoulos C; Opie R; Castle D; Dash S; Brazionis L; Berk M; Jacka F
BMC Public Health; 2018 May; 18(1):599. PubMed ID: 29783983
[TBL] [Abstract][Full Text] [Related]
10. Protocol for a within-trial economic evaluation of a psychoeducational intervention tailored to people at high risk of developing a second or subsequent melanoma.
Dieng M; Cust AE; Kasparian NA; Butow P; Costa DS; Menzies SW; Mann GJ; Morton RL
BMJ Open; 2016 Oct; 6(10):e012153. PubMed ID: 27855094
[TBL] [Abstract][Full Text] [Related]
11. Topotecan, pegylated liposomal doxorubicin hydrochloride and paclitaxel for second-line or subsequent treatment of advanced ovarian cancer: a systematic review and economic evaluation.
Main C; Bojke L; Griffin S; Norman G; Barbieri M; Mather L; Stark D; Palmer S; Riemsma R
Health Technol Assess; 2006 Mar; 10(9):1-132. iii-iv. PubMed ID: 16545208
[TBL] [Abstract][Full Text] [Related]
12. Examining the preliminary efficacy of an intervention for fear of cancer recurrence in female cancer survivors: a randomized controlled clinical trial pilot study.
Tomei C; Lebel S; Maheu C; Lefebvre M; Harris C
Support Care Cancer; 2018 Aug; 26(8):2751-2762. PubMed ID: 29500582
[TBL] [Abstract][Full Text] [Related]
13. Study protocol of the CAREST-trial: a randomised controlled trial on the (cost-) effectiveness of a CBT-based online self-help training for fear of cancer recurrence in women with curatively treated breast cancer.
van Helmondt SJ; van der Lee ML; de Vries J
BMC Cancer; 2016 Jul; 16():527. PubMed ID: 27455846
[TBL] [Abstract][Full Text] [Related]
14. Complaint-Directed Mini-Interventions for Depressive Symptoms: A Health Economic Evaluation of Unguided Web-Based Self-Help Interventions Based on a Randomized Controlled Trial.
Wijnen BF; Lokman S; Leone S; Evers SM; Smit F
J Med Internet Res; 2018 Oct; 20(10):e10455. PubMed ID: 30274958
[TBL] [Abstract][Full Text] [Related]
15. The clinical effectiveness and cost-effectiveness of cardiac resynchronisation (biventricular pacing) for heart failure: systematic review and economic model.
Fox M; Mealing S; Anderson R; Dean J; Stein K; Price A; Taylor RS
Health Technol Assess; 2007 Nov; 11(47):iii-iv, ix-248. PubMed ID: 17999842
[TBL] [Abstract][Full Text] [Related]
16. Septoplasty versus non-surgical management for nasal obstruction in adults with a deviated septum: economic evaluation alongside a randomized controlled trial.
van Egmond MMHT; Grutters JPC; Hannink G; van Heerbeek N; Rovers MM
BMC Med; 2020 May; 18(1):101. PubMed ID: 32354362
[TBL] [Abstract][Full Text] [Related]
17. Effectiveness, Cost-effectiveness, and Cost-Utility of a Digital Alcohol Moderation Intervention for Cancer Survivors: Health Economic Evaluation and Outcomes of a Pragmatic Randomized Controlled Trial.
Mujcic A; Blankers M; Boon B; Berman AH; Riper H; van Laar M; Engels R
J Med Internet Res; 2022 Feb; 24(2):e30095. PubMed ID: 35103605
[TBL] [Abstract][Full Text] [Related]
18. Costs and cost-effectiveness of a mental health intervention for war-affected young persons: decision analysis based on a randomized controlled trial.
McBain RK; Salhi C; Hann K; Salomon JA; Kim JJ; Betancourt TS
Health Policy Plan; 2016 May; 31(4):415-24. PubMed ID: 26345320
[TBL] [Abstract][Full Text] [Related]
19. Cost-utility analysis of a treatment advice to discontinue inappropriate long-term antidepressant use in primary care.
Eveleigh R; Grutters J; Muskens E; Oude Voshaar R; van Weel C; Speckens A; Lucassen P
Fam Pract; 2014 Oct; 31(5):578-84. PubMed ID: 25121977
[TBL] [Abstract][Full Text] [Related]
20. ConquerFear-group: Feasibility study with pilot results of a psychological intervention for fear of cancer recurrence delivered in groups.
Tauber NM; Zachariae R; Jensen AB; Thewes B; Skyt I; Elkjaer E; Butow PN; O'Toole MS
Psychooncology; 2022 Jan; 31(1):30-38. PubMed ID: 34289212
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
